2019 Webinar CEU Series Replay

PIM Logo.png
ADA webinar.png
TAP logo.jpg

Support: This activity received support in the form of unrestricted educational grants from Amplifon and Colgate Oral Pharmaceuticals

 

 Estimated time to complete individual activities: 1 hour

 For any questions relating to the certification for this activity, please contact Postgraduate Institute for Medicine at: inquiries@pimed.com or (303) 799-1930.

 Jointly provided by Postgraduate Institute for Medicine and The Audiology Project

January 22, 2019

Pharmacy: Optimal Diabetes Care- The Pharmacists Role in a Changing Health Care World

Speaker: Susan Cornell, PharmD - Midwestern University

Abstract: Healthcare models are evolving from an acute care (wait until it breaks) structure to a chronic care (prevent it from breaking) formation of care. The team based approach to optimal patient care requires all healthcare professionals to work at the top of their license and training. Pharmacists have long been underutilized, especially in diabetes education, management and care. This session will review the scope and types of pharmacy practice, including community, hospital, primary and specialty care, in which pharmacists educate, manage and care for people with diabetes.

Release date: February 1, 2019

Expiration date: December 31, 2019


February 26, 2019

Podiatry and Diabetes Care: Working together to manage diabetes

SPEAKER: DENNIS R. FRISCH, DPM - PRESIDENT, AMERICAN PODIATRIC MEDICAL ASSOCIATION

Abstract: This lecture will discuss common foot problems found in the diabetic patient. Podiatry in diabetes care delivers a critical health service that helps to underwrite health and personal independence, while reducing isolation and depression. This webinar will educate the inter professional collaboration team (PPOD+A and medical diabetes care professionals), regarding foot care, ensuring the person with diabetes receives best possible foot/podiatric care and quality of life. The attendees will understand basic foot issues so that patients can be appropriately questioned and referred.

Release date: MARCH 5, 2019

Expiration date: December 31, 2019


March 26, 2019. 12:30-1:30pm EST, 9:30am PST

You, Optometry and Diabetes: Core Concepts, Drivers and Bridges to Interdisciplinary Care

SPEAKER: MICHAEL R. DUEÑAS, OD, FNAP- CHIEF PUBLIC HEALTH OFFICER, AMERICAN OPTOMETRIC ASSOCIATION

Abstract: This webinar will discuss all forms of diabetic eye disease that have the potential to cause severe vision loss and blindness. These conditions include diabetic retinopathy, diabetic macular edema (DME), cataract, and glaucoma. It will help to educate the inter professional collaboration team (PPOD+A and medical diabetes care professionals), on the theory and practice of diabetes eye care delivery, to empower them to influence patient health outcomes in positive and meaningful ways. We will explore the epidemiology of diabetes, drivers to reducing diabetes complications, bridges to early T2DM prevention and detection, new research & therapies and current & proposed health policy. 

RELEASE DATE: March 31, 2019

EXPIRATION DATE: DECEMBER 31, 2019


April 23, 2019. 12:30-1:30pm ET

Bridging the Interprofessional Collaboration Gap Regarding the Oral Health of People With Diabetes

SPEAKER: DR. JERRY BROWN DMD, CDE, DENTIST AND DIABETES EDUCATOR, UNIVERSITY OF SOUTH FLORIDA, INTERNAL MEDICINE

Abstract: This presentation will deal with some of the dental issues experienced by people living with diabetes, as well as how dentists will be collaborating with the other healthcare professionals involved in the care of people with this chronic disease. Suggestions will be made as to how dental healthcare professionals, and all of the other healthcare professionals, can and should improve their communication, and collaboration.

Release date: April 25, 2019

Expiration date: December 31, 2019


 

Privacy Policy: https://www.logmeininc.com/legal/privacy

Concerns or complaints about a CE Provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at www.ada.org/cerp." to the ADA credit designation statement.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or 5 suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.